Literature DB >> 33919175

New Cocrystals of Antipsychotic Drug Aripiprazole: Decreasing the Dissolution through Cocrystallization.

Wenwen Liu1, Ru Ma1, Feifei Liang1, Chenxin Duan1, Guisen Zhang1,2, Yin Chen1, Chao Hao1,2.   

Abstract

Cocrystallization is an important route to tuning the solubility in drugs development, including improving and reducing. Five cocrystals of aripiprazole (ARI) with resveratrol (RSV) and kaempferol (KAE), ARI-RSV, ARI2-RSV1·MeOH, ARI-KAE, ARI-KAE·EtOH, ARI-KAE·IPA, were synthesized and characterized. The single crystal of ARI2-RSV1·MeOH, ARI-KAE·EtOH, and ARI-KAE·IPA were analyzed by single crystal X-ray diffraction (SCXRD). The SCXRD showed multiple intermolecular interactions between API and the coformers, including hydrogen bond, halogen bond, and π-π interactions. Dissolution rate of the two nonsolvate ARI-RSV and ARI-KAE cocrystals were investigated through powder dissolution experiment in pH = 4.0 acetate buffer and pH = 6.8 phosphate buffer. The result showed that RSV could reduce the dissolution rate and solubility of ARI in both medium through cocrystallization. However, KAE improved the dissolution rate and solubility of ARI in pH = 4.0 medium, on the contrary, the two solubility indicators of ARI were both reduced for ARI-KAE cocrystal.

Entities:  

Keywords:  aripiprazole; cocrystal; dissolution rate; kaempferol; resveratrol

Year:  2021        PMID: 33919175     DOI: 10.3390/molecules26092414

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  23 in total

1.  Aripiprazole: polymorphs and solvatomorphs.

Authors:  Harry G Brittain
Journal:  Profiles Drug Subst Excip Relat Methodol       Date:  2012-03-19

Review 2.  Multidrug co-crystals: towards the development of effective therapeutic hybrids.

Authors:  Rajesh Thipparaboina; Dinesh Kumar; Rahul B Chavan; Nalini R Shastri
Journal:  Drug Discov Today       Date:  2016-02-08       Impact factor: 7.851

3.  Bioavailability of indomethacin-saccharin cocrystals.

Authors:  Min-Sook Jung; Jeong-Soo Kim; Min-Soo Kim; Amjad Alhalaweh; Wonkyung Cho; Sung-Joo Hwang; Sitaram P Velaga
Journal:  J Pharm Pharmacol       Date:  2010-11       Impact factor: 3.765

Review 4.  The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.

Authors:  Örn Almarsson; Matthew L Peterson; Michael Zaworotko
Journal:  Pharm Pat Anal       Date:  2012-07

5.  Performance comparison of a co-crystal of carbamazepine with marketed product.

Authors:  Magali B Hickey; Matthew L Peterson; Lisa A Scoppettuolo; Sherry L Morrisette; Anna Vetter; Hector Guzmán; Julius F Remenar; Zhong Zhang; Mark D Tawa; Sean Haley; Michael J Zaworotko; Orn Almarsson
Journal:  Eur J Pharm Biopharm       Date:  2006-12-28       Impact factor: 5.571

Review 6.  Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.

Authors:  Tracy Swainston Harrison; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.

Authors:  Gislaine Kuminek; Fengjuan Cao; Alanny Bahia de Oliveira da Rocha; Simone Gonçalves Cardoso; Naír Rodríguez-Hornedo
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

Review 8.  Aripiprazole.

Authors:  Febry Ardiana; Maria L A D Lestari; Gunawan Indrayanto
Journal:  Profiles Drug Subst Excip Relat Methodol       Date:  2013

9.  Resveratrol cocrystals with enhanced solubility and tabletability.

Authors:  Zhengzheng Zhou; Wanying Li; Wei-Jhe Sun; Tongbu Lu; Henry H Y Tong; Changquan Calvin Sun; Ying Zheng
Journal:  Int J Pharm       Date:  2016-06-06       Impact factor: 5.875

Review 10.  A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals.

Authors:  Arun Kumar; Sandeep Kumar; Arun Nanda
Journal:  Adv Pharm Bull       Date:  2018-08-29
View more
  2 in total

1.  Superior Dissolution Behavior and Bioavailability of Pharmaceutical Cocrystals and Recent Regulatory Issues.

Authors:  Meng Y Xia; Bing Q Zhu; Jian-R Wang; Ze E Yang; Xue F Mei
Journal:  ACS Med Chem Lett       Date:  2021-12-30       Impact factor: 4.345

2.  Two Novel Palbociclib-Resorcinol and Palbociclib-Orcinol Cocrystals with Enhanced Solubility and Dissolution Rate.

Authors:  Chenxin Duan; Wenwen Liu; Yunwen Tao; Feifei Liang; Yanming Chen; Xinyi Xiao; Guisen Zhang; Yin Chen; Chao Hao
Journal:  Pharmaceutics       Date:  2021-12-23       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.